Full-Time

VP – Life Sciences

Updated on 11/20/2024

Iterative Health

Iterative Health

51-200 employees

AI-driven solutions for gastrointestinal healthcare

AI & Machine Learning
Healthcare

Senior, Expert

Remote in USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Sales
Requirements
  • Deep network of biopharma / biotech contacts and relationships across clinical research, development and operations
  • Experience in an MSL, medical affairs or clinical operations role at a biopharma/biotech or CRO
  • Sales-minded individual with experience carrying multi-million dollar books of business
  • Experience across gastroenterology and/or hepatology
  • Experience and interest in people management
  • Aptitude for collaborating cross-functionally to drive business growth
  • Strong written/verbal and external communication and interpersonal skills
Responsibilities
  • Drive pipeline of CTO development, including pitching and positioning capabilities, pricing, negotiations, etc.
  • Engage existing partners to ensure the success of current projects, as well as develop new growth areas
  • Partner with internal staff and external leaders to provide direction, answer questions, and resolve issues related to trials strategy
  • Participate in CTO leadership meetings and translate strategic objectives into operational execution

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve patient outcomes globally.

Company Stage

Series B

Total Funding

$182.1M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-9%

1 year growth

-18%

2 year growth

-25%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $150 million Series B funding round positions Iterative Health for accelerated growth and innovation in AI-driven GI care.
  • Strategic partnerships with major GI groups like Gastro Health and One GI® expand their clinical research capabilities and market reach.
  • Recognition of their leadership, such as Jonathan Ng being named to the PharmaVoice 100, underscores the company's influence and potential in the healthcare sector.

What critics are saying

  • The specialized focus on GI care may limit market opportunities compared to broader healthcare AI applications.
  • Integration challenges from recent acquisitions could disrupt operations and slow down innovation.

What makes Iterative Health unique

  • Iterative Health leverages AI and ML specifically for gastrointestinal care, setting it apart from broader healthcare AI applications.
  • Their FDA-cleared SKOUT® device enhances physician accuracy in detecting adenomas, a unique offering in colorectal cancer prevention.
  • The company's AI-enabled documentation technology standardizes high-quality reporting, making advanced GI care accessible to underserved populations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off